Cite
Overview of current systemic management of EGFR-mutant NSCLC.
MLA
Hsu, W. H., et al. “Overview of Current Systemic Management of EGFR-Mutant NSCLC.” Annals of Oncology, vol. 29, Jan. 2018, pp. i3–9. EBSCOhost, https://doi.org/10.1093/annonc/mdx702.
APA
Hsu, W.-H., Yang, J. C.-H., Mok, T. S., & Loong, H. H. (2018). Overview of current systemic management of EGFR-mutant NSCLC. Annals of Oncology, 29, i3–i9. https://doi.org/10.1093/annonc/mdx702
Chicago
Hsu, W -H, J C -H Yang, T S Mok, and H H Loong. 2018. “Overview of Current Systemic Management of EGFR-Mutant NSCLC.” Annals of Oncology 29 (January): i3–9. doi:10.1093/annonc/mdx702.